The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Nutrichem's LDN Book Events with Linda Elsegood (Low dose naltrexone) from LDN Research Trust on Vimeo.
The LDN Book Volume 2 & The Goals of the LDN Research Trust
Low-dose naltrexone: tricking the body to heal itself
Exp Biol Med (Maywood)
September 2011
https://www.sciencedaily.com/releases/2011/09/110902133047.htm
Low Dose Naltrexone Treatment of Established Relapsing-Remitting Experimental Autoimmune Encephalomyelitis
J Multiple Sclerosis
January 2015
https://www.researchgate.net/publication/281496691_Low_Dose_Naltrexone_Treatment_of_Established_Relapsing-Remitting_Experimental_Autoimmune_Encephalomyelitis
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial
Mult Scler
August 2010
https://pubmed.ncbi.nlm.nih.gov/20534644/
Bee Venom Therapy and Low Dose Naltrexone for Treatment of Multiple Sclerosis
Nepal J Neurosci
January 2006
https://www.researchgate.net/publication/283504677_Bee_Venom_Therapy_and_Low_Dose_Naltrexone_for_Treatment_of_Multiple_Sclerosis
Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?
Med Hypotheses
February 2006
https://pubmed.ncbi.nlm.nih.gov/16759815/
Inducible nitric oxide synthase is thought to be responsible for inflammatory nitric oxide concentrations in the brains of patients with MS and those with autism. It is proposed that low-dose naltrexone reduces nitric oxide synthase, thus acts as an anti-inflammatory agent.
Low dose naltrexone therapy in multiple sclerosis
Med Hypotheses
24 September 2004
https://pubmed.ncbi.nlm.nih.gov/15694688/
Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics
Neurotherapeutics
October 2017
https://pubmed.ncbi.nlm.nih.gov/28779373/
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
PLoS One
03 November 2017
https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0187423
Featured Article: Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone
Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/